neostigmine has been researched along with Apoplexy in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, AJ | 1 |
| Zang, P | 1 |
| Guo, JM | 1 |
| Wang, W | 1 |
| Dong, WZ | 1 |
| Guo, W | 1 |
| Xiong, ZG | 1 |
| Wang, WZ | 1 |
| Su, DF | 1 |
1 other study available for neostigmine and Apoplexy
| Article | Year |
|---|---|
Involvement of acetylcholine-α7nAChR in the protective effects of arterial baroreflex against ischemic stroke.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Baroreflex; Brain Ischemia; Cells, Cultured; Male; | 2012 |